Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wickenden

Showing results (191-200 of 194) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 194 results.
Bioorganic & Medicinal Chemistry Letters|October 12, 2010
1,2-diamino-ethane-substituted-6,7,8,9-tetrahydro-5H-pyrimido[4,5-d]azepines as TRPV1 antagonists with improved propertiesAlec D Lebsack, Jason C Rech, Bryan J Branstetter, et al.
European Journal of Pharmacology|May 18, 2011
Characterization of 2-(2,6-dichloro-benzyl)-thiazolo[5,4-d]pyrimidin-7-yl]-(4-trifluoromethyl-phenyl)-amine (JNJ-39729209) as a novel TRPV1 antagonistMichael P Maher, Anindya Bhattacharya, Hong Ao, et al.
Journal of Medicinal Chemistry|May 12, 2017
4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical CandidateMichael A Letavic, Brad M Savall, Brett D Allison, et al.
The Journal of Clinical Investigation|July 15, 2025
Organ-specific features of human kidney lymphatics are disrupted in chronic transplant rejectionDaniyal J Jafree, Benjamin J Stewart, Karen L Price, et al.
Pageof 20

Showing results (191-200 of 194) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 194 results.
Bioorganic & Medicinal Chemistry Letters|October 12, 2010
1,2-diamino-ethane-substituted-6,7,8,9-tetrahydro-5H-pyrimido[4,5-d]azepines as TRPV1 antagonists with improved propertiesAlec D Lebsack, Jason C Rech, Bryan J Branstetter, et al.
European Journal of Pharmacology|May 18, 2011
Characterization of 2-(2,6-dichloro-benzyl)-thiazolo[5,4-d]pyrimidin-7-yl]-(4-trifluoromethyl-phenyl)-amine (JNJ-39729209) as a novel TRPV1 antagonistMichael P Maher, Anindya Bhattacharya, Hong Ao, et al.
Journal of Medicinal Chemistry|May 12, 2017
4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical CandidateMichael A Letavic, Brad M Savall, Brett D Allison, et al.
The Journal of Clinical Investigation|July 15, 2025
Organ-specific features of human kidney lymphatics are disrupted in chronic transplant rejectionDaniyal J Jafree, Benjamin J Stewart, Karen L Price, et al.
Pageof 20